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Abstract 
Background: Preventive chemotherapy delivered via mass drug administration (MDA) is essential for the control of 
neglected tropical diseases (NTDs), including lymphatic filariasis (LF), schistosomiasis and onchocerciasis. Success-
ful MDA relies heavily on community drug distributor (CDD) volunteers as the interface between households and 
the health system. This study sought to document and analyse demand-side (households) and supply-side (health 
system) factors that affect MDA delivery in Liberia.
Methods: Working in two purposively selected counties, we conducted a household MDA access and adherence 
survey; a CDD survey to obtain information on direct and opportunity costs associated with MDA work; an obser-
vational survey of CDDs; and key informant surveys (KIS) with community-level health workers. Data from the CDD 
survey and Liberian minimum wage rates were used to calculate the opportunity cost of CDD participation per 
MDA round. The observational data were used to calculate the time spent on individual household-level tasks and 
CDD time costs per house visited. KIS data on the organisation and management of the MDA in the communities, 
and researcher reflections of open-ended survey responses were thematically analysed to identify key demand- and 
supply-side challenges.
Results: More respondents were aware of MDA than NTD in both counties. In Bong, 39% (103/261) of respondents 
reported taking the MDA tablet in the last round, with “not being informed” as the most important reason for non-
adherence. In Maryland, 56% (147/263) reported taking MDA with “being absent” at the time of distribution being 
important for non-adherence. The mean cost per CDD of participating in the MDA round was −$11.90 (median $5.04, 
range −$169.62 to $30.00), and the mean time per household visited was 17.14 min which equates to a mean oppor-
tunity cost of $0.03 to $0.05 per household visited. Thematic analysis identified challenges, including shortages of and 
delays in medicine availability; CDD frustration over costs; reporting challenges; and household concerns about drug 
side effects.
Conclusions: Improved adherence to MDA and subsequent elimination of NTDs in Liberia would be supported 
by an improved medicine supply chain, financial compensation for CDDs, improved training, healthcare workforce 
strengthening, greater community involvement, capacity building, and community awareness.
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Background
Neglected tropical diseases (NTDs) are a group of 20 
diseases that have historically received scant attention 
and are concentrated among individuals with very low 
incomes [1, 2]. Preventive chemotherapy delivered via 
mass drug administration (MDA) is essential for the con-
trol of NTDs including lymphatic filariasis (LF), schisto-
somiasis and onchocerciasis [2]. Low and/or inequitable 
MDA coverage challenges NTD program effectiveness, 
the achievement of the new 2030 NTD elimination tar-
gets [3–5], and the overarching goal of universal health 
coverage [6]. Heavy reliance on drug donations and vol-
unteers such as community drug distributors (CDDs) 
threatens MDA sustainability [1, 3].
Liberia is situated on the west coast of Africa bordered 
by Sierra Leone, Guinea, Cote d’Ivoire and the Atlantic 
Ocean, with a population of 5.05 million people. Oncho-
cerciasis, LF and schistosomiasis are endemic throughout 
Liberia and are the most common infections among its 
poorest communities [7, 8]. Guided by their NTD Mas-
ter Plan, the Liberian Ministry of Health and partners 
sought to eliminate LF, onchocerciasis and schistosomia-
sis by 2020 [9, 10] through a combination of annual MDA 
with ivermectin (IVM) and albendazole (ABD); disability 
management and inclusion; and vector control [7].
The national NTD program led its first 3 yearly MDA 
campaigns with IVM and ABD in 2012–2013 achieving 
82% coverage [11]. Household acceptability and adher-
ence to MDA and the volunteering efforts of CDDs made 
this possible. CDDs have been at the forefront of drug 
(and bed net) distribution since 2012, with some individ-
ual CDDs having over 10 years of experience. The Ebola 
virus disease (EVD) outbreak in Liberia (2014–2015) 
severely disrupted public health programs for NTDs 
including MDA [12]. Following containment of the EVD 
outbreak in 2015, the Liberian Ministry of Health and 
partners restarted MDA in 2017 [12].
CDDs are considered the primary care providers at the 
community level. However, health system and program-
related factors such as inadequate training and super-
vision of CDDs by health facility staff have an adverse 
impact on CDD performance [9, 10]. CDDs also incur 
direct (financial expenditure) and opportunity costs 
(indirect costs) for their participation in MDA programs. 
Opportunity cost is defined as the cost of the next-best 
opportunity foregone, and in the case of CDDs, this 
is time that could otherwise be spent on paid work or 
unpaid activities such as caring or food production (sub-
sistence agriculture). In Liberia, CDDs’ financial com-
pensation is dependent on the availability of funds [9, 10], 
and hence direct and opportunity costs incurred may not 
be covered, presenting a barrier to their participation in 
MDA.
This paper presents an analysis of accessibility and 
adherence to MDA in the post-EVD context from the 
household, CDD and health system perspective in Libe-
ria. Its findings will help support the Liberian govern-
ment and partners to move towards equitable attainment 
of NTD elimination goals and will be of interest to poli-
cymakers and implementers facing similar challenges and 
wishing to develop resilient health systems [8].
The study objective was to document and analyse fac-
tors that affect accessibility and adherence to MDA on 
the demand-side (households) and supply-side (health 
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system) in Liberia. Specific aims were to (i) determine 
household accessibility and adherence to MDA; (ii) doc-
ument and quantify the direct and opportunity costs of 
CDD participation in MDA; and (iii) describe resources 
used in conducting MDA programs at the community 
level, and identify demand- and supply-side challenges 
that adversely affect MDA delivery.
Methods
Study components
We addressed the study aims through the following four 
components: household survey on MDA accessibility 
and adherence (HHS) (aim 1); CDD costs survey (CDD 
CS) (aim 2); CDD observational (time and motion) sur-
vey during household MDA delivery (CDD TM) (aim 2); 
key informant surveys with health workers, community 
health workers and community leaders to explore com-
munity-level resources needed for MDA delivery (KIS) 
and a qualitative synthesis of findings (Aim 3).
Sampling strategy
For all four components, we purposively selected two 
counties where all three diseases of interest (LF, oncho-
cerciasis and schistosomiasis) are endemic, where the 
population resides in predominantly rural areas (reflect-
ing the majority of the Liberian population) and from 
different geographical regions of Liberia. The selected 
counties, Bong in Central Liberia and Maryland in 
South-east Liberia, have similar levels of household 
wealth across all quintiles, although Bong has higher, and 
Maryland lower, illiteracy levels compared to the national 
average [9]. Bong had higher EVD cases than Maryland, 
with health systems and communities consequently more 
badly affected by the epidemic. The NTD burden, and 
geographic and therapeutic program coverage also varies 
between the two counties.
Within each county, we used a multi-stage sampling 
process (Fig.  1) [13]. First, we randomly selected three 
districts, then we randomly selected three communities 
from each district, yielding nine communities per county. 
Once communities had been identified, the sample selec-
tion process was different for each study component. For 
the HHS, we obtained a list of all households from the 
community head and randomly selected 29 households 
per community. CDDs are attached to the community 
with each one covering a 5-km radius for their work. 
We planned to select all CDDs from the 18 communi-
ties for inclusion in the CDD CS and to identify up to 
10 CDDs (six Bong, four Maryland) to participate in the 
CDD TM, based on those actively conducting MDA dur-
ing the time that the research team was in the commu-
nity. For component four (KIS), we aimed to select up to 
15 key informants per county, including health workers 
and community leaders. We aimed to include different 
types of health workers of different genders and experi-
ences within practical constraints such as availability 
and willingness to participate. The target sample size and 
the number achieved are shown by study component in 
Table 1. 
Data collection and analysis
We assigned a team leader and four enumerators to one 
community at a time to collect data for each study com-
ponent on Android tablets using Survey CTO, between 
November 2017 and June 2018.
Household survey (HHS)
We conducted interviews with consenting house-
hold heads using a questionnaire containing open and 
closed-ended questions to collect data on knowledge 
about NTDs and MDA; accessibility and adherence to 
MDA; MDA drug acceptance; and information sources 
on MDA. Survey data were analysed to produce indica-
tors of NTD awareness (heard or not heard of NTDs); 
MDA awareness (as for NTD); whether the respondent 
took MDA tablets  in the last round and if not why; and 
to identify the most important sources of information on 
MDA by county and gender.
Purposive sample: Bong and Maryland County
Random sample: three districts per county 
Random sample: three communities per district 
Consents to being interviewed
Questionnaire or survey administered
Random sample: 29 households per community for household survey
Include all CDDs from each community in cost survey
Practical selection of up to 10 CDDs for time and motion study
Purposively select up to 15 key informants per community
Fig. 1 Study sampling frame
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Capturing and analysing CDD costs (CDD CS and CDD TM)
For the CDD CS, we used a questionnaire contain-
ing open and closed-ended questions on involvement 
in MDA activities including CDDs role and experience 
in training, collection and distribution of drugs, costs 
incurred, days worked in the MDA, monthly salaries for 
their main occupation and any allowances received for 
MDA participation. Direct costs incurred by CDDs dur-
ing the last MDA round were calculated by summing all 
reported expenditure on food and transportation costs 
during MDA training and drug distribution. Direct costs, 
minus allowances reported, were used to calculate net 
direct costs [14]. CDD opportunity cost was calculated 
by multiplying the number of days worked on MDA 
activities by the value of their time. CDD time was val-
ued using three alternative indicators. Firstly, we used the 
CDDs’ reported wage or salary for their main occupation 
to impute their daily wage (imputed daily wage [IDW]). 
We also obtained data on the Liberian minimum wages 
for unskilled workers and, separately, civil servants [15] 
which we considered skilled workers. These rates were 
converted to two daily wage rates, minimum daily wage 
unskilled (MDWU) and skilled (MDWS). The total cost 
to CDDs per MDA round was calculated by summing the 
net direct costs and the estimated opportunity cost [14]. 
Results are presented as means and medians for the sam-
pled CDDs.
The CDD TM was an observational study where the 
enumerators followed consenting CDDs during their 
household rounds using a stopwatch to record the time 
spent on each separate task in each household. Tasks 
were coded into a sub-set of the five most reported tasks 
and then used to calculate the time spent on different 
tasks, the mean time and CDD opportunity cost per 
house visited using MDWU and MDWS.
All cost data were in Liberian dollars and converted to 
US dollars using the 2018 exchange rate (1 LRD = 0.0050 
USD) [16]. We cleaned and analysed all quantitative data 
in Excel [17]
Qualitative data collection and analysis (KIS)
The KIS included questions about the organisation and 
management of the MDA in the communities with a 
focus on resource use and constraints. Both the KIS and 
CDD CS contained open-ended questions which enabled 
respondents to provide free-text responses. In addition, 
the survey drew on the experiences and comments of 
the researcher, including critical reflections from their 
interactions with the CDDs’ key informants. We collated 
and reviewed all free-text data for key themes related to 
resources needed to implement MDA. We used a frame-
work approach to identify emerging themes from the 
open-ended questions and critical reflection data [18]. 
This involved (i) reviewing the data to identify emerg-
ing themes, both inductively and deductively, based on 
emerging findings from the quantitative analysis; (ii) gen-
erating a coding framework to apply to the data based 
on emerging themes; (iii) applying the coding frame-
work and charting the data to identify synergies between 
themes; and (iv) synthesising findings at a higher level 
linked to demand- and supply-side factors as presented 
in the results [18] (Additional file 1: Table S1).
Results
Descriptive statistics
For the HHS, we obtained 524 (261 Bong, 263 Maryland) 
household head interviews (51% male, 49% female) with 
just over half (53%) coming from the 26–49 age group. 
Twenty-four CDDs (nine Bong, 15 Maryland) com-
pleted the CDD CS, with females making up 25% of the 
total sample. Ten CDDs (six Bong, four Maryland) were 
Table 1 Respondent type, inclusion criteria, target and actual sample size by study component
a Last MDA round included Onco and LF (Maryland) and LF (Bong)
Study component Respondent type Inclusion criteria Sample size
Target Actual
Bong Maryland Total Bong Maryland Total
1 Household MDA access and 
adherence survey (HHS)
Household members Lived in community during last 
MDA  rounda
260 260 520 261 263 524
3 CDD cost survey (CDD CS) CDDs Assigned to the sampled com-
munity
15 14 29 9 15 24
2 CDD time and motion study 
(CDD TM)
CDDs Participated in last MDA round 15 14 29 6 4 10
4 Key informant survey (KIS) Health workers, community 
health workers and community 
leaders
Works in/assigned to the sam-
pled community
18 12 30 15 13 28
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observed for the CDD TM with only one of these being 
female. Twenty-eight respondents (15 Bong, 13 Mary-
land) completed the KIS with 39% female (Table 2).
Household accessibility and adherence to MDA (HHS)
More respondents were aware of MDA than NTD in 
both counties (heard of NTD 13% vs heard of MDA 
44%, and 4% vs 25% Bong and Maryland, respectively). 
Awareness of NTD in Bong was 8% among males and 
17% among females, while in Maryland, it was 5% and 
2%, respectively. Awareness of MDA in Bong was 43% 
and 46% (males and females, respectively) and 24% and 
26%, respectively, in Maryland. (It is important to note 
the above results reflect the diverse ways that NTDs and 
MDA are referred to in the communities and that MDA 
was a relatively new concept for some communities, e.g., 
schistosomiasis in Maryland; this diversity may not have 
been fully reflected in our standardised survey tools.) A 
lower proportion of males and females reported taking 
tablets during MDA in Bong than Maryland (Bong 40% 
male and 40% female, vs Maryland 57% and 55%, respec-
tively). The main reason for males and females report-
ing not taking the tablet in Bong was not being informed 
about the MDA activities (male = 22%, female = 24%, 
both sexes = 23%). In Maryland, for males, it was due to 
not being informed (9%) or being absent during the MDA 
activities (female = 20% and both sexes = 14%). The most 
cited sources of MDA information in both counties (and 
sexes) were town criers (Table 3).
Estimated costs incurred by CDDs throughout the MDA 
round
The mean reported direct costs incurred by CDDs 
during the MDA round was $4.17 (median $2.00, range 
$0.00 to 15.00). Reported mean allowance received 
per CDD/round was $15.27 ($16.50, $0.00 to $30.00), 
resulting in a mean net income of $11.10 per CDD/
round ($8.13, −$4.00 to $30.00). Mean reported CDD 
monthly salary was $29.27, yielding an imputed daily 
wage rate of $1.13 ($0.04, $0 to $12.12). Multiplying 
the mean reported number of days spent on MDA 
activity per round per CDD (mean 16.04, median 14, 
range 2 to 33) by the imputed daily wage rate, mini-
mum daily wage for unskilled and, separately, skilled 
workers, yields estimated mean indirect costs incurred 
per CDD per MDA round of $23.00 ($0.27, $0.00 to 
$169.62), $12.90 ($11.26, $1.61 to $26.53) or $23.15 
($20.20, $2.89 to $47.62). Subtracting the indirect costs 
from the net direct income (or expenditure if negative) 
shows that mean cost to CDDs of participating in the 
MDA round was −$11.90 ($5.04, −$169.62 to $30.00), 
−$1.79 ($3.12, −$24.53 to $22.37) or −$12.05 (−$6.15, 
−$45.62 to $17.9) using the IDW, MDWU and MDWS 
time valuation methods (negative sign implies cost, 
positive is income gain), respectively (Table 4).
Household and opportunity costs incurred by all observed 
CDDs per household visited during MDA (CDD TM)
We observed 10 CDDs for a total of 4645 min in which 
they undertook 271 household visits to deliver MDA. 
CDDs conducted a range of tasks with ‘Measuring 
and drug administration’ taking the most time (mean 
8.24  min) followed by ‘record-keeping and registra-
tion’ (mean 5.14  min). The mean time per household 
visited was 17.14 min. (Table 5). Using the MDWU and 
MDWCS to value this time yields an opportunity cost to 
the CDD of $0.03–0.05 per house visited.
Qualitative findings on community‑level resource use 
and constraints for MDA delivery (KIS)
Key informants in both counties reported that drugs 
for MDA were supplied by the government and non-
governmental organisations (NGOs) and confirmed that 
the communities bore no costs for drug purchase and 
transportation. Bong reported the use of wooden and 
cemented buildings for community-level MDA meet-
ings, while Maryland reported no buildings used for the 
running of the MDA program. Bong reported the use 
of three NGO-rented motorcycles during MDA, while 
Maryland reported using two government-rented motor-
cycles. Other equipment used in both counties included 
generators, flip charts, audio and video equipment, meg-
aphones and measuring sticks.
Respondents cited several demand-side challenges to 
effective MDA such as the important role of community 
leaders in supporting MDA and identified challenges 
around expectations for communities to provide ‘com-
pensation’ to CDDs, concerns over side effects, and trust 
issues. On the supply side, challenges to effective MDA 
delivery included shortages and delays in medicine avail-
ability; frustration among CDDs particularly concerning 
costs and poor compensation; and reporting challenges 
(Additional file 1: Table S1) [19].
Discussion
This study used mixed (quantitative and qualitative) 
methods to identify and explore community (demand-
side) and health system (supply-side) challenges which 
could potentially affect MDA coverage.
Our results showed low levels of awareness about 
MDA and lower levels of awareness of NTDs in both 
counties. We found that 48% of people reported taking 
the MDA tablets during the last round, with the most 
common reasons for not adhering being because they 
were not around when it was being delivered or were 
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not informed about the delivery. This emphasises the 
importance of ensuring MDA timing and organisation 
is cognisant of daily and seasonal activities in specific 
communities [19–22]. As part of the capacity- and 
awareness-building target of the NTD roadmap to 
2030, awareness-generation activities to educate and 
inform the endemic communities are deemed essential 
[10], and positive community leader influence and com-
munity trust is vital for effective healthcare delivery 
[23]. Indeed, we found that community leaders encour-
aged the community to listen to the message from town 
criers, which was where most respondents reported 
Table 2 Descriptive statistics by study component
a Disability status was defined using the Washington group of questions on the difficulty in carrying out basic activities (seeing, hearing, walking, self-care, cognition 
and communication)
Study component Indicator Category Bong Maryland Total
N % N % N %
1. Household MDA access and adherence 
survey (HHS)
Gender Male 130 50 136 52 266 51
Female 131 50 127 48 258 49
Total 261 100 263 100 524 100
Age 18–25 20 8 11 4 31 6
26–49 136 52 140 53 276 53
Over 49 74 28 85 32 159 30
Not disclosed 31 12 27 10 58 11
Total 261 100 263 100 524 100
Disability  statusa Disability 28 11 26 10 54 10
No disability 233 89 237 90 470 90
Total 261 100 263 100 524 100
2. CDD cost survey (CDD CS) Gender Male 8 88.9 10 66.7 18 75
Female 1 11.1 5 33.3 6 25
Total 9 100 15 100 24 100
Occupation Farming 4 44.4 2 13.3 6 25
Forest ranger 0 0 1 6.7 1 4.1
Retired nurse 1 11.1 0 0 1 4.1
Student 0 0 6 40 6 25
Teacher 2 22.2 2 13.3 4 16.7
Volunteer 1 11.1 3 20 4 16.7
Business 1 11.1 1 6.7 2 8.3
Total 9 100 15 100 24 100
3. CDD time and motion study (CDD TM) Occupation Farming 2 33.3 1 30 3 30
Forest ranger 0 0 1 0 1 10
Retired nurse 1 16.7 0 20 1 10
Student 1 16.7 1 0 2 20
Teacher 0 0 1 0 1 10
Volunteer 1 16.7 0 50 1 10
Business 1 16.7 0 0 1 10
Total 6 100 4 100 10 100
4. Key informant survey (KIS) Gender Male 9 60 8 62 17 61
Female 6 40 5 38 11 39
Total 15 100 13 100 28 100
Role Town chief 5 33 4 31 9 32
District Surveillance Officer 1 7 0 0 1 4
Community Health Surveillance Supervisor 4 27 5 38 9 32
Officer in charge 5 33 1 8 6 21
Community Development Chairperson 0 0 3 23 3 11
Total 15 100 13 100 28 100
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getting information from in the household survey. 
More could be done to enhance the role of community 
leaders in supporting MDA, which should, in turn, gen-
erate trust and community ownership of MDA, with 
likely benefits for coverage and adherence [24–26].
We found that the Liberian CDDs spent an average of 
16.04 workdays in the MDA round, similar to the 13.31 
workdays a year on NTD activities including MDA in 
Uganda [27]. Our quantitative findings indicate that 
Liberian CDDs incurred direct and opportunity costs for 
taking part in MDA and that for some CDDs, these costs 
were not adequately compensated by allowances, result-
ing in a mean cost to CDDs of $11.90. Placing this into 
context, the minimum monthly wage for civil servants in 
Liberia is $37.52 (5600 Liberian dollars). This led to frus-
tration among CDDs, which were reflected in our quali-
tative findings and have been identified in other settings 
[11, 26–28].
From our KIS survey, we discovered that communities 
were expected to compensate CDDs via providing gifts 
in kind such as a cup of rice or a small fee in exchange 
for medicines to CDDs. Some health staff described 
that community members were often unable or unwill-
ing to do this due to their level of income and/or socio-
economic status and so avoided the CDD. With the high 
incidence of extreme poverty in the communities receiv-
ing MDA and possible deterrence [29–31], this leads us 
to question the viability of such an approach on equity 
and efficiency grounds and a potential risk to the achieve-
ment of NTD targets on equitable access to healthcare 
[10]
Our observations of CDDs during their MDA activities 
identified that two tasks accounted for a large proportion 
of their time, namely measuring and drug administration, 
and record-keeping and registration. However, qualita-
tive findings indicated that transportation for CDDs was 
also a challenge, and they found it difficult to move within 
communities to distribute drugs. Motorcycles were lim-
ited and insufficient to reach out and serve communities, 
making the workload greater for CDDs as they walked 
longer distances, taking up more time to distribute drugs 
and incurring higher direct and opportunity costs by the 
Table 3 Knowledge of and adherence to NTDs and MDA for Bong and Maryland, Liberia
a Some respondents cited more than one option, which is why totals are different from other indicators
b Missing or no data
Knowledge/adherence Responses and sub-totals Bong Maryland Grand 
total
Male Female Total Male Female Total
N % N % N % N % N % N % N %
NTD awareness Heard of NTD 11 8 22 17 33 13 7 5 3 2 10 4 43 8
Not heard of NTD 100 77 101 78 201 77 108 79 120 94 228 87 429 82
Missingb 19 15 6 5 27 10 21 15 4 3 25 10 52 10
Total 130 100 129 100 261 100 136 100 127 100 263 100 524 100
MDA awareness Heard of MDA 56 43 59 46 115 44 33 24 33 26 66 25 181 35
Not heard of MDA 55 42 64 50 119 46 81 60 89 70 170 65 289 55
Missingb 19 15 6 5 27 10 22 16 5 4 27 10 54 10
Total 130 100 129 100 261 100 136 100 127 100 263 100 524 100
Took tablets during recent MDA round Yes 52 40 51 40 103 39 77 57 70 55 147 56 250 48
No Reason for not taking tablet during recent MDA round
Absent 16 12 10 8 26 10 11 8 25 20 36 14 62 12
Do not know 2 2 2 2 4 2 9 7 8 6 17 6 21 4
Not informed 28 22 31 24 59 23 12 9 4 3 16 6 75 14
Pregnant 0 0 7 5 7 3 0 0 5 4 5 2 12 2
Sick 0 0 1 1 1 0 1 1 1 1 2 1 3 1
Other 13 10 22 17 35 13 6 4 12 9 18 7 53 10
Missingb 19 15 5 4 26 10 20 15 2 2 22 8 48 9
Total 130 100 129 100 261 100 136 100 127 100 263 100 524 100
Source of information on  MDAa Town crier 81 59 81 60 162 59 60 41 72 59 132 49 294 54
Radio 32 23 33 24 65 24 35 24 18 15 53 20 118 22
Hospital 25 18 21 16 46 17 52 35 32 26 84 31 130 24
Total 138 100 135 100 273 100 147 100 122 100 269 100 542 100
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end of the MDA. Support to compensate CDDs for the 
costs incurred during their role in MDA delivery and for 
more efficient transport would likely bring benefits in 
terms of greater satisfaction and retention, supporting 
the NTD road map for 2021–2030 [10].
Creating awareness and educating households on MDA 
and its benefits and side effects of drugs was relatively 
time-consuming for CDDs at each household. Hence, 
low awareness increased the workload and consequently 
the opportunity cost incurred by the CDDs in our study 
and in others [21, 26]. CDDs could be better supported 
during MDA with access to materials to support conver-
sations about the reasons for the MDA and drug safety 
information to reassure households [24, 32, 33].
Having an adequate supply of quality-assured medi-
cines and an efficient supply chain at the community 
level is critical for the effective allocation and distribution 
of medicines. However, as in other studies, we found that 
drug shortages made it difficult for CDDs to effectively 
distribute drugs to the target population [34]. Similarly, 
delayed distribution due to drug shortages confused both 
CDDs and the communities, hampering adherence when 
the MDA happened [24]. Furthermore, even though most 
CDDs attended at least one training session, many had 
limited training on how to complete reporting forms, and 
consequently, they submitted incomplete records which 
in turn compromised programmatic-level medicine esti-
mates [35]. These findings highlight the critical impor-
tance of NTD monitoring and evaluation mechanisms 
and suggest that investment in improved CDD training 
may yield programmatic benefits [10].
Recall bias is inherent in any study relying on household 
surveys, and this study is no exception. The recruitment 
of female CDDs was challenging due to fewer females 
acting as CDDs in the study communities because of pre-
existing gender norms, competing domestic priorities, 
and reduced literacy levels compared to their male coun-
terparts [29, 30]. We also faced capacity challenges that 
affected the quality of some of the data collected. Anal-
ysis of the household survey results on NTD and MDA 
awareness revealed many missing or no responses. On 
investigation, it was found that this was due to confusion 
and lack of understanding of the diverse range of defini-
tions and local terminologies used to refer to NTDs and 
MDA in the different communities. Unfortunately, due to 
internet connectivity problems and the community pro-
cess of data collection, this was not picked up until it was 
too late to alter the survey tool. This may have led to an 
underestimate of NTD and MDA awareness in our study.
MDA activities were measured in this study by follow-
ing the CDDs and using a stopwatch to record time spent 
on each activity. Unfortunately, time spent by CDDs in 
houses was only recorded in minutes (not minutes and 
seconds) which may have affected results. In Uganda, a 
similar study used pictures and drawings to describe the 
entire day of the CDD during NTD activities, bringing 
in more context to the opportunity costs borne by these 
CDDs [27]. This approach might have worked well in the 
Table 5 Time and opportunity cost by CDDs per MDA household, in Bong and Maryland, Liberia
NB: stopwatch data were recorded in full minutes; na: not applicable. A–J represent anonymised individual CDDs













A 209 0 105 49 217 19 599 25
B 422 2 36 117 133 22 732 25
C 241 48 0 61 176 0 526 29
D 271 9 3 1 147 0 431 30
E 354 18 37 102 101 7 619 27
F 114 28 0 40 114 7 303 25
G 271 69 7 40 272 7 666 52
H 156 25 2 79 115 11 388 29
I 182 41 5 17 114 0 359 28
J 12 0 1 5 4 0 22 1
Total (all CDDs) 2232 240 196 511 1393 73 4645 271
Total time per task (mean) 223.2 24 19.6 51.1 139.3 7.3 464.5 27.1
Time per household by task (mean) 8.24 0.89 0.72 1.89 5.14 0.27 17.14 na
Opportunity cost MDWU (mean) ($) 0.01 0.001 0.001 0.003 0.008 0.0004 0.03 na
Opportunity cost MDWCS (mean) ($) 0.02 0.002 0.002 0.005 0.015 0.0008 0.05 na
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Liberian context; however, it would not have yielded a 
quantitative estimate of costs per house, highlighting the 
benefits of complementary quantitative and qualitative 
research in understanding health systems.
The data collection limitations of this study highlight 
the need for continued investment in health research 
capacity strengthening in low- and middle-income coun-
tries. Nevertheless, this work represents a first effort at 
conducting a mixed-methods health economic study of 
NTDs in Liberia and thus a major step forward in health 
systems research for the country.
Conclusion
Community drug distributors are the interface between 
the supply- and demand-sides of the health system dur-
ing MDA and appear to face challenges from both sides. 
Improved remuneration to meet opportunity cost of 
MDA participation would likely help to address this 
and further strengthening the community-level health 
systems.
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